PLK1 and non-small cell lung carcinoma: First, to understand the clinical relevance between PLK1 and β-catenin in NSCLC, the overall survival (OS) of 1,292 NSCLC patients was analyzed using datasets (GSE14814, GSE29013, GSE31210, GSE37745, GSE50081, and GSE4573) from KM PLOTTER 33 (Figure 1A, Figure S2, and Table S1).